ask Ask a question
Favorite

The assay for AChE inhibition was based upon the method of Ellman et al. [55], but modified for a 96-well microtiter plate format, as reported in Nwidu et al. [54]. In a microtiter plate, 40 μL of plant extract (at concentrations of 200, 20, 2, 0.2 and 0.02 µg/mL) was mixed with 35 µL of 50 mM Tris-HCl (pH 8.0) containing 0.1% BSA, 50 μL of 3 mM DTNB, and 50 µL of AChE. The AChE used was either from electric eel at 1 mg/mL (Sigma, Poole, UK) or that present within rat brain homogenate (prepared at 10% (w/v), according to the procedure of Carter et al. [56,57], which had been diluted 1:10 in 10 mM Tris-HCl pH 8.0 for assays. Plates were incubated at 37 °C for 5 min before the cholinesterase reaction initiated by the addition of 25 μL of 15 mM ATCI substrate, resulting in the production of 5-thio-2-nitrobenzoate anion that was read at 412 nm every 5 s for 10 min using a Spectramax microplate reader (Thermo Fisher, Stafford, UK). Eserine was employed at 0.02 µg/mL as a positive control for AChE inhibition. At this concentration (or above), eserine inhibits AChE to ≈100% [55]. All reactions were performed in triplicates, from which an average reading was generated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A